trial · primary record
Acute Treatment Interruption
HIV
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2029-08-01 |
| Primary endpoint | Fold increase in HIV nucleic acids (RNA and DNA) in blood or lymphoid compartments from baseline to 10 day ATI vs baseline to no ATI. |
| Registry ID | NCT05419024 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:45.120Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05419024
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
